189 related articles for article (PubMed ID: 16007190)
41. Differential gene expression identifies subgroups of renal cell carcinoma.
Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
[TBL] [Abstract][Full Text] [Related]
42. Expression of apoptotic tumour necrosis factor receptor-associated factor, caspase recruitment domain and cell death-inducing DFF-45 effector genes in therapy-treated renal cell carcinoma.
Rajandram R; Pat BK; Li J; Johnson DW; Gobe GC
Nephrology (Carlton); 2009 Apr; 14(2):205-12. PubMed ID: 19076291
[TBL] [Abstract][Full Text] [Related]
43. Down-regulation of hepatic nuclear factor 4alpha on expression of human hepatic stimulator substance via its action on the proximal promoter in HepG2 cells.
Guo D; Dong LY; Wu Y; Yang L; An W
Biochem J; 2008 Oct; 415(1):111-21. PubMed ID: 18513187
[TBL] [Abstract][Full Text] [Related]
44. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
[TBL] [Abstract][Full Text] [Related]
45. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
[TBL] [Abstract][Full Text] [Related]
46. Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma.
Diegmann J; Tomiuk S; Sanjmyatav J; Junker K; Hindermann W; von Eggeling F
Int J Mol Med; 2006 Sep; 18(3):395-403. PubMed ID: 16865223
[TBL] [Abstract][Full Text] [Related]
47. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase.
Aoki H; Satoh M; Mitsuzuka K; Ito A; Saito S; Funato T; Endoh M; Takahashi T; Arai Y
FEBS Lett; 2004 Jun; 567(2-3):203-8. PubMed ID: 15178323
[TBL] [Abstract][Full Text] [Related]
49. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
[TBL] [Abstract][Full Text] [Related]
50. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
[TBL] [Abstract][Full Text] [Related]
51. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
52. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
53. Significance of gene expression analysis of renal cell carcinoma.
Leppert JT; Pantuck AJ
Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
[TBL] [Abstract][Full Text] [Related]
54. Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth.
Gómez Román JJ; Garay GO; Saenz P; Escuredo K; Sanz Ibayondo C; Gutkind S; Junquera C; Simón L; Martínez A; Fernández Luna JL; Val-Bernal JF
Transl Res; 2008 Mar; 151(3):134-40. PubMed ID: 18279812
[TBL] [Abstract][Full Text] [Related]
55. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
56. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
57. Transcription profiling of renal cell carcinoma.
Huber W; Boer JM; von Heydebreck A; Gunawan B; Vingron M; Füzesi L; Poustka A; Sültmann H
Verh Dtsch Ges Pathol; 2002; 86():153-64. PubMed ID: 12647365
[TBL] [Abstract][Full Text] [Related]
58. Targeted insertion of an IRES Cre into the Hnf4alpha locus: Cre-mediated recombination in the liver, kidney, and gut epithelium.
Vincent SD; Robertson EJ
Genesis; 2004 Jul; 39(3):206-11. PubMed ID: 15282747
[TBL] [Abstract][Full Text] [Related]
59. HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
Stickel JS; Weinzierl AO; Hillen N; Drews O; Schuler MM; Hennenlotter J; Wernet D; Müller CA; Stenzl A; Rammensee HG; Stevanović S
Cancer Immunol Immunother; 2009 Sep; 58(9):1407-17. PubMed ID: 19184600
[TBL] [Abstract][Full Text] [Related]
60. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles.
Furge KA; Lucas KA; Takahashi M; Sugimura J; Kort EJ; Kanayama HO; Kagawa S; Hoekstra P; Curry J; Yang XJ; Teh BT
Cancer Res; 2004 Jun; 64(12):4117-21. PubMed ID: 15205321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
